Literature DB >> 23105360

Alteration of serum beta 2-microglobulin in oral carcinoma.

C R Wilma Delphine Silvia1, D M Vasudevan, K Sudhakar Prabhu.   

Abstract

Serum β(2)-microglubin (β(2)-m) levels were measured in oral carcinoma patients and compared with normal healthy controls. It was observed that there was a significant rise in serum β(2)-microglobulin in oral carcinoma patients. Progressively higher values were obtained as the cancer advanced clinically. Therefore the estimation of serum β(2)-microglobulin may be useful as one of a battery of tests in the assessment of oral carcinoma patients.

Entities:  

Keywords:  Oral carcinoma; β2-microglobulin

Year:  2002        PMID： 23105360      PMCID： PMC3454116          DOI： 10.1007/BF02867981

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN： 0970-1915


  14 in total

1.  Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia.

Authors:  J Rodriguez; J Cortes; M Talpaz; S O'Brien; T L Smith; M B Rios; H Kantarjian
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

2.  Serum beta 2 microglobulin and its prognostic value in lymphomas.

Authors:  P L Amlot; M Adinolfi
Journal:  Eur J Cancer       Date:  1979-05       Impact factor: 9.162

3.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

4.  Serum 2 -microglobulin in various disorders.

Authors:  P E Evrin; L Wibell
Journal:  Clin Chim Acta       Date:  1973-01-24       Impact factor: 3.786

5.  Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients.

Authors:  J A Child; B Spati; S Illingworth; D Barnard; S Corbett; A V Simmons; J Stone; T S Worthy; E H Cooper
Journal:  Cancer       Date:  1980-01-15       Impact factor: 6.860

6.  Serum beta 2 microglobulin in oral malignancy and premalignancy.

Authors:  C Scully
Journal:  J Oral Pathol       Date:  1981-10

7.  Diagnosis of head and neck carcinomas by means of immunological tumour markers (Beta-2-microglobulin, immunoglobulin E, ferritin, N-acetyl-neuraminic acid, phosphohexose-isomerase).

Authors:  K Vinzenz; E Schönthal; F Zekert; S Wunderer
Journal:  J Craniomaxillofac Surg       Date:  1987-10       Impact factor: 2.078

8.  Immunological manifestations of HIV-infected children.

Authors:  B S Eley; J Hughes; S Potgieter; M Keraan; J Burgess; G D Hussey
Journal:  Ann Trop Paediatr       Date:  1999-03

9.  beta 2-microglogulin levels in cancerous and other disease states.

Authors:  J Shuster; P Gold; M D Poulik
Journal:  Clin Chim Acta       Date:  1976-03-15       Impact factor: 3.786

Review 10.  The biological markers of non-Hodgkin's lymphomas: their role in diagnosis, prognostic assessment and therapeutic strategy.

Authors:  E Morra
Journal:  Int J Biol Markers       Date:  1999 Jul-Sep       Impact factor: 3.248
View more
  5 in total

1.  Serum beta-2 microglobulin analysis in patients with oral squamous cell carcinoma.

Authors:  Joyce Sequeira; Shreya Sengupta; Bhupendra Mhatre
Journal:  Natl J Maxillofac Surg       Date:  2021-07-15

2.  Estimation of Serum Beta 2-Microglobulin Levels in Individuals Exposed to Carcinogens: Clinical Study in Indian Population.

Authors:  Rashmi Saddiwal; Manjula Hebbale; Vikrant Dilip Sane; Darshan Hiremutt; Rohan Gupta; Yash Merchant
Journal:  J Maxillofac Oral Surg       Date:  2016-05-13

3.  Estimation of serum β2-microglobulin in potentially malignant disorders and squamous cell carcinoma of the oral cavity: A clinicopathological study.

Authors:  Anand Pratap Singh; Nitin Kumar; Manthena Srinivasa Raju; Narendra Nath Singh; Suma Gundareddy Nagendrareddy
Journal:  Dent Res J (Isfahan)       Date:  2014-01

4.  Blood biomarkers in adults with lymph node enlargement contribute to diagnostic significance of malignancy.

Authors:  Shanshan Ma; Junbin Guo; Danlei Lu; Lixia Zhu; Meng Zhou; Li Li; Jingjing Zhu; Xiudi Yang; Yanlong Zheng; Xiujin Ye; Wanzhuo Xie
Journal:  Oncotarget       Date:  2017-10-23

5.  The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population.

Authors:  Na Li; Dingrong Zhong; Huang Chen; Tiequn Huang; Pihua Hou; Yinan Zhang; Fangling Chen; Xiaoping Wang; Hongchun Zhang
Journal:  Cancer Manag Res       Date:  2019-05-06       Impact factor: 3.989
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.